Targeting the oncogenic protein beta-catenin to enhance chemotherapy outcome against solid human cancers.

Targeting the oncogenic protein beta-catenin to enhance chemotherapy outcome against solid human cancers.

Item
http://www.wikidata.org/entity/Q34153051
Novel cancer chemotherapy hits by molecular topology: dual Akt and Beta-catenin inhibitorsRepeated ovarian stimulation does not affect the expression level of proteins involved in cell cycle control in mouse ovaries and fallopian tubes.Plasma membrane proteomics of human breast cancer cell lines identifies potential targets for breast cancer diagnosis and treatment.PKC-β as a therapeutic target in CLL: PKC inhibitor AEB071 demonstrates preclinical activity in CLL.Ras regulates SCF(β-TrCP) protein activity and specificity via its effector protein NORE1A.Accumulation of memory precursor CD8 T cells in regressing tumors following combination therapy with vaccine and anti-PD-1 antibody.Inhibitory effects of lupeal acetate of Cortex periplocae on N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesisPharmacological modulation of beta-catenin and its applications in cancer therapyOncoprotein stabilization in brain tumors.A Nexus Consisting of Beta-Catenin and Stat3 Attenuates BRAF Inhibitor Efficacy and Mediates Acquired Resistance to Vemurafenib.Dishevelled1-3 contribute to multidrug resistance in colorectal cancer via activating Wnt/β-catenin signaling.Selenium targets resistance biomarkers enhancing efficacy while reducing toxicity of anti-cancer drugs: preclinical and clinical development.
P2860

Targeting the oncogenic protein beta-catenin to enhance chemotherapy outcome against solid human cancers.

Item
http://www.wikidata.org/entity/Q34153051
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Targeting the oncogenic protei ...... e against solid human cancers.
@ast
Targeting the oncogenic protei ...... e against solid human cancers.
@en
Targeting the oncogenic protei ...... e against solid human cancers.
@nl
type
label
Targeting the oncogenic protei ...... e against solid human cancers.
@ast
Targeting the oncogenic protei ...... e against solid human cancers.
@en
Targeting the oncogenic protei ...... e against solid human cancers.
@nl
prefLabel
Targeting the oncogenic protei ...... e against solid human cancers.
@ast
Targeting the oncogenic protei ...... e against solid human cancers.
@en
Targeting the oncogenic protei ...... e against solid human cancers.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Targeting the oncogenic protei ...... e against solid human cancers.
@en
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P6179
P698
P921
P932